We are live on ! Find out more

Fidelity MSCI Health Care Index ETF

FHLC

Market cap $3.43B

81.44 USD

+1.14

1.42%

At close Updated Sep 14, 4:00 PM EDT

1 day

1.42%

5 days

-0.62%

1 month

0.12%

3 months

10.32%

6 months

13.05%

Year to date

9.23%

1 year

24.15%

5 years

23.23%

10 years

138.69%

News

Positive

Neutral

Negative

Sentiment 3-Months

Positive 28.6%

Neutral 64.3%

Negative 7.1%

Tackle Market Uncertainty With Strategic Healthcare Exposure

With much of the attention in the capital markets directed towards the technology sector, it's easy to forget other sectors like healthcare. However, it's key to consider other sectors within your portfolio to help hedge against heavy volatility.

Tackle Market Uncertainty With Strategic Healthcare Exposure

The Motley Fool

Which Healthcare ETF Is the Better Buy: Fidelity's Broad FHLC or State Street's Pharma-Focused XPH?

Fidelity MSCI Health Care Index ETF offers a lower expense ratio of 0.08% compared to the 0.35% charged by State Street SPDR S&P Pharmaceuticals ETF. State Street SPDR S&P Pharmaceuticals ETF focuses specifically on the pharmaceutical industry, whereas Fidelity MSCI Health Care Index ETF tracks the broader healthcare sector.

Which Healthcare ETF Is the Better Buy: Fidelity's Broad FHLC or State Street's Pharma-Focused XPH?

Health Care's Next Act: Tailwinds Emerging Across R&D Cycle

Pharmaceuticals are rebounding as U.S. drug pricing clarity emerges, shifting focus to patent expirations and innovation-driven differentiation. Companies like JNJ and AZN, with diversified portfolios and strong R&D pipelines, are better positioned to offset looming patent cliffs.

Health Care's Next Act: Tailwinds Emerging Across R&D Cycle

The Motley Fool

Healthcare ETF Comparison: Fidelity's FHLC vs. Invesco's Biotech-Focused IBBQ

The Fidelity MSCI Health Care Index ETF features a lower expense ratio of 0.08% and a higher dividend yield of 1.2%. The Invesco Nasdaq Biotechnology ETF has delivered a higher 1-year total return of 56.4% but carries a more significant maximum drawdown of 37.9%.

Healthcare ETF Comparison: Fidelity's FHLC vs. Invesco's Biotech-Focused IBBQ

Big Pharma's Comeback Is Here: Winners, Losers, And 4 ETFs

Nine of the 16 Big Pharma stocks covered in this article set new 52-week highs during August, reflecting strong momentum across the sector. Also, the rally has been driven by strong Q2 results, as well as Wall Street's growing shift toward healthcare amid continued geopolitical tensions in the Middle East.

Big Pharma's Comeback Is Here: Winners, Losers, And 4 ETFs

The Motley Fool

FHLC vs. PJP: Which Healthcare ETF Is the Better Buy for Investors?

Fidelity MSCI Health Care Index ETF (FHLC) offers a significantly lower expense ratio and a higher dividend yield than the Invesco Pharmaceuticals ETF (PJP). PJP provides a concentrated portfolio of just over 30 pharmaceutical stocks, while FHLC diversifies across more than 300 holdings.

FHLC vs. PJP: Which Healthcare ETF Is the Better Buy for Investors?

Health Care Shakes Off A 5-Day Slide

Health Care ended a five-day losing streak on Wednesday with a 1.34% rally. The streak tied the five days ending June 18 for the sector's longest of 2026.

Health Care Shakes Off A 5-Day Slide

The Motley Fool

Healthcare Stocks Are Having a Good Year. Should You Buy a Fidelity or iShares ETF to Profit?

Fidelity MSCI Health Care Index ETF carries a significantly lower expense ratio of 0.08% compared to 0.38% for iShares U.S. Healthcare ETF Fidelity MSCI Health Care Index ETF provides broader exposure with 334 holdings, while iShares U.S. Healthcare ETF is more concentrated with 100 positions Both funds exhibit similar risk profiles with five-year maximum drawdowns near 18% and nearly identical beta measurements

Healthcare Stocks Are Having a Good Year. Should You Buy a Fidelity or iShares ETF to Profit?

The Motley Fool

XLV vs FHLC: Which Healthcare ETF Fits Your Portfolio?

The State Street Health Care Select Sector SPDR ETF manages $41.7 billion in assets under management (AUM), providing significantly higher liquidity than the Fidelity MSCI Health Care Index ETF Fidelity MSCI Health Care Index ETF tracks a broader universe of 365 holdings compared to the concentrated 60-stock portfolio of the State Street fund Both healthcare funds share an identical 0.08% expense ratio, making them some of the most cost-efficient options in the sector

XLV vs FHLC: Which Healthcare ETF Fits Your Portfolio?

Zacks Investment Research

Should You Invest in the Fidelity MSCI Health Care Index ETF (FHLC)?

Designed to provide broad exposure to the Healthcare - Broad segment of the equity market, the Fidelity MSCI Health Care Index ETF (FHLC) is a passively managed exchange traded fund launched on October 21, 2013.

Should You Invest in the Fidelity MSCI Health Care Index ETF (FHLC)?

See News Rankings

Price charts implemented using Lightweight Charts™